An observational study in Metabolic Syndrome, sponsored by Ataturk Training and Research Hospital. Status unknown at 2 sites in Turkey. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2017-11-17.
Sponsored by Ataturk Training and Research Hospital · Observational
Among 53 studies in Metabolic Syndrome with a site in Turkey — 13 open to participants now, 15 under way, none of them phase 3. Metabolic Syndrome · Turkey.
Among the 53 studies in Metabolic Syndrome with a site in Turkey, this one is the 18th largest by planned enrollment of the 33 observational ones that give a count, is the only one that started in 2015, is one of 33 observational ones, and was the 10th registered.
2,116 studies on the registry are indexed under Metabolic Syndrome; 347 are open to participants now.
Browse Metabolic Syndrome studies →13 of the 53 studies in Metabolic Syndrome with a site in Turkey are open now. Recruiting first, the newest first:
Karamanoğlu Mehmetbey University · Sites in Turkey
Sisli Hamidiye Etfal Training and Research Hospital · Sites in Turkey
Abant Izzet Baysal University · Sites in Turkey
Yaşar Bayındır, MD · Sites in Turkey
Istanbul University - Cerrahpasa · Sites in Turkey
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 232 Metabolic Syndrome studies recruiting now, 68 (29%) set no upper age limit and 136 (59%) stop at 75 or younger; 20 take children under 18; 80 take healthy volunteers.
This study: 20 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
53 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 1 started in 2015.
This study's planned enrollment of 100 is below the median of 197 across 496 observational studies indexed under Metabolic Syndrome.
Median enrollment 76 across the 20 interventional studies, 104 across the 33 observational. Of the 33 that completed or were terminated, 4 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 53 have an industry lead sponsor. The 10 most frequent:
Ataturk Training and Research Hospital is the lead sponsor of 24 studies on the registry; 1 is open to participants now.
Ataturk Training and Research Hospital has 1 study filed under Metabolic Syndrome — fewer than ten, so there is no comparison to draw.
5 of the studies in Metabolic Syndrome with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07890155Sisli Hamidiye Etfal Training and Research HospitalEffect of Resistance Exercises on Serum IGF-1 Levels in Knee Osteoarthritis | 2026-12-01 |
| NCT07643376Toros UniversityEvaluation of Metabolic Parameters, Intestinal Permeability and Gastrointestinal Symptoms After Bariatric Surgery in Body Weight Management | 2027-01-01 |
| NCT07731360Kayseri City HospitalNon-Invasive Diagnostic Panel for MASLD in Children With Obesity | 2027-04-01 |
| NCT07731373Kayseri City HospitalBiomarker Panel for PCOS-Associated Liver Steatosis in Adolescent Girls (COMPASS-pedPCOS) | 2027-04-30 |
| NCT07737340Yaşar Bayındır, MDMetabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR) | 2027-05 |
Among the 53 studies in Metabolic Syndrome with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study was to investigate the serum concentrations, physical and psychological well-being characteristics in patients having chronic musculoskeletal pain with metabolic syndrome, and to compare patients without metabolic syndrome.
Metabolic syndrome (MetS) is a combination of metabolic risk factors such as impaired glucose level, dyslipidemia, hypertension, and central obesity. MetS has become a large public health issue with common interrelation to different accompanying disorders. Moreover, the link between MetS and musculoskeletal disorders has previously been demonstrated.
Presence and prevalence of MetS in patients having musculoskeletal pain seems common and interrelated.However, to our knowledge, manifestations with clinical symptoms of MetS, some inflammatory markers via serum concentrations and physical and psychological health profiles of patients with seeking treatment from outpatient physical therapy for musculoskeletal pain conditions have not been researched up to now.
patients having chronic musculoskeletal pain with and without metabolic syndrome
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
To be a volunteer patient with a chronic non-specific musculoskeletal pain disorder, including knee osteoarthritis, rotator cuff tear, adhesive capsulitis, and non-specific low back, back or neck pain for more than 6 months.
Exclusion Criteria:
the presence of severe physical disability, psychiatric disorder, malignant tumors, pregnancy, chronic alcohol consumption, gout, heart failure, liver and renal dysfunction.
To be a volunteer patient with a chronic non-specific musculoskeletal pain disorder, including knee osteoarthritis, rotator cuff tear, adhesive capsulitis, and non-specific low back, back or neck pain for more than 6 months.
Other: Body composition · Other: Physical activity level · Other: Musculoskeletal pain intensity · Other: Quality of life · Other: Psychological Well-Being · Diagnostic Test: Blood tests
To be a volunteer patient with a chronic non-specific musculoskeletal pain disorder, including knee osteoarthritis, rotator cuff tear, adhesive capsulitis, and non-specific low back, back or neck pain for more than 6 months.
Other: Body composition · Other: Physical activity level · Other: Musculoskeletal pain intensity · Other: Quality of life · Other: Psychological Well-Being · Diagnostic Test: Blood tests
evaluated by Bodystat®1500 Bio-impedance Analyzer
assessed by the International Physical Activity Questionnaire-7
evaluated with Visual Analog Scale
assessed by the Nottingham Health Profile
assessed by the Hospital Anxiety and Depression Scale
Blood tests included serum glucose, triglyceride, high-density lipoprotein cholesterol (HDL-C), and uric acid levels. Blood samples were collected from the patients after one night of fasting.
Blood tests
for uric acid levels.
Time frame: 2 years
Body composition
evaluated by Bodystat®1500 Bio-impedance Analyzer
Time frame: 2 years
Physical activity level
assessed by the International Physical Activity Questionnaire-7. The intensity of self-reported physical activity, lasting at ten minutes per bout, was used to assess metabolic equivalent (MET). The MET is defined as the ratio of a working metabolic rate to a standard resting metabolic rate.MET-minutes/week was computed by multiplying the MET score of an activity (3.3 for walking, 4.0 for moderate-intensity, and 8.0 for vigorous-intensity) by the minutes and days performed. The summation of walking, moderate, and vigorous METs-minutes/week enabled the computation of the total physical activity performed by an individual.
Time frame: 2 years
The musculoskeletal pain intensity
evaluated with 0 to 10 cm Visual Analog Scale. "0" indicated "no pain" and the "10" indicated "the worst imaginable pain".
Time frame: 2 years
Quality of life
evaluated with the Nottingham Health Profile (NHP). It contains 38 items divided into 6 dimensions: NHP-energy, NHP-pain, NHP-emotional reactions, NHP sleep, NHP-social isolation, and NHP-physical mobility. All the parameters are summed as NHP-total. The respondent answers "yes" if the statement adequately reflected the current status or feeling, or "no" otherwise. Dimension scores ranged from 0 (no problems) to 100 (maximum problems).
Time frame: 2 years
Psychological Well-Being (Anxiety and Deppression condition)
evaluated with the Hospital Anxiety and Depression Scale (HADS). Each question was scored on a 4-point Likert scale, ranging from 0 to 3, where a higher score represented more severe anxiety or depression.
Time frame: 2 years
Plan to share: Undecided
Started Aug 2015 (actual). Primary completion is estimated for Nov 2017, 27 months after the start.
Of 149 non-industry observational studies under Metabolic Syndrome, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 106. This study's planned 27 months is below that.
Counting every sponsor, half of 160 studies reached it within 42 months; a quarter within 18 and three quarters within 106.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ataturk Training and Research Hospital